Izabela T.
- Country
- Poland
- Department
- NA
Research Overview
- Phase III Study on Immunogenicity and Safety of MenACYW Conjugate Vaccine Versus Nimenrix in Healthy Infants and Toddlers
- Phase 3 Multicenter Randomized Placebo-Controlled Trial Evaluating Efficacy, Safety, and Immunogenicity of VLA15 Vaccine for Lyme Disease in Individuals Aged ≥5 Years
- Evaluation of Safety, Tolerability, and Immunogenicity of MenABCWY-2nd Gen Vaccine in Healthy Infants with Meningococcal Infections
Data & Insights
Has run more than one trial at 15 of 78 partner sites.
Specializations
Meningococcal Disease Prevention
This investigator specializes in researching meningococcal vaccine development, with particular focus on innovative conjugate vaccines targeting multiple serogroups.
- ACYW conjugate vaccine studies
- Immunogenicity assessment in infants and toddlers
- Multi-serogroup vaccine formulations
Their research encompasses comprehensive evaluation of vaccine safety profiles and immune responses in pediatric populations.
Vaccine Development
The investigator conducts research in advanced vaccine formulations, focusing on next-generation preventive solutions.
- Multi-component vaccine development
- Comparative vaccine studies
- Safety and reactogenicity assessment
Their work includes evaluation of different vaccine generations and formulation improvements.
Lyme Disease Prevention
The investigator explores innovative approaches to Lyme disease prevention through vaccine development and clinical evaluation.
- 6-Valent OspA-based vaccine research
- Age-specific immune response studies
- Vaccine lot consistency evaluation
Their research extends to comprehensive efficacy assessment across different age groups and seasonal variations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.